Aclaris Therapeutics Inc

XNAS: ACRS

Download real time

1.23 -0.10 (-7.52%)

76.21% Fall from 52W High

947.8K XNAS Volume

XNAS 08 Apr, 2025 5:30 PM (EDT)

133

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Aclaris Therapeutics Inc - ACRS - stock price prediction, stock price target, analyst ratings from 6 analysts

Aclaris Therapeutics Inc has a share price target of US$ 10, revenue growth forecast of -23.2%, and profit growth estimate of 37.9% for FY25, based on top 6 analyst calls.

Forecaster Screeners